Literature DB >> 25745888

Deep comparative genomics among Chlamydia trachomatis lymphogranuloma venereum isolates highlights genes potentially involved in pathoadaptation.

Vítor Borges1, João Paulo Gomes2.   

Abstract

Lymphogranuloma venereum (LGV) is a human sexually transmitted disease caused by the obligate intracellular bacterium Chlamydia trachomatis (serovars L1-L3). LGV clinical manifestations range from severe ulcerative proctitis (anorectal syndrome), primarily caused by the epidemic L2b strains, to painful inguinal lymphadenopathy (the typical LGV bubonic form). Besides potential host-related factors, the differential disease severity and tissue tropism among LGV strains is likely a function of the genetic backbone of the strains. We aimed to characterize the genetic variability among LGV strains as strain- or serovar-specific mutations may underlie phenotypic signatures, and to investigate the mutational events that occurred throughout the pathoadaptation of the epidemic L2b lineage. By analyzing 20 previously published genomes from L1, L2, L2b and L3 strains and two new genomes from L2b strains, we detected 1497 variant sites and about 100 indels, affecting 453 genes and 144 intergenic regions, with 34 genes displaying a clear overrepresentation of nonsynonymous mutations. Effectors and/or type III secretion substrates (almost all of those described in the literature) and inclusion membrane proteins showed amino acid changes that were about fivefold more frequent than silent changes. More than 120 variant sites occurred in plasmid-regulated virulence genes, and 66% yielded amino acid changes. The identified serovar-specific variant sites revealed that the L2b-specific mutations are likely associated with higher fitness and pointed out potential targets for future highly discriminatory diagnostic/typing tests. By evaluating the evolutionary pathway beyond the L2b clonal radiation, we observed that 90.2% of the intra-L2b variant sites occurring in coding regions involve nonsynonymous mutations, where CT456/tarp has been the main target. Considering the progress on C. trachomatis genetic manipulation, this study may constitute an important contribution for prioritizing study targets for functional genomics aiming to dissect the impact of the identified intra-LGV polymorphisms on virulence or tropism dissimilarities among LGV strains.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chlamydia trachomatis; Genetic variability; Lymphogranuloma venereum; Pathoadaptation; Proctitis

Mesh:

Year:  2015        PMID: 25745888     DOI: 10.1016/j.meegid.2015.02.026

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  11 in total

1.  Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors.

Authors:  Vítor Borges; Miguel Pinheiro; Minia Antelo; Daniel A Sampaio; Luís Vieira; Rita Ferreira; Alexandra Nunes; Filipe Almeida; Luís J Mota; Maria J Borrego; João P Gomes
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

2.  Bioinformatic Analysis of Chlamydia trachomatis Polymorphic Membrane Proteins PmpE, PmpF, PmpG and PmpH as Potential Vaccine Antigens.

Authors:  Alexandra Nunes; João P Gomes; Karuna P Karunakaran; Robert C Brunham
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 3.  Chlamydia trachomatis Genital Infections.

Authors:  Catherine M O'Connell; Morgan E Ferone
Journal:  Microb Cell       Date:  2016-09-05

4.  CteG is a Chlamydia trachomatis effector protein that associates with the Golgi complex of infected host cells.

Authors:  Sara V Pais; Charlotte E Key; Vítor Borges; Inês S Pereira; João Paulo Gomes; Derek J Fisher; Luís Jaime Mota
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

5.  Chlamydia trachomatis: when the virulence-associated genome backbone imports a prevalence-associated major antigen signature.

Authors:  Vítor Borges; Dora Cordeiro; Ana Isabel Salas; Zohra Lodhia; Cristina Correia; Joana Isidro; Cândida Fernandes; Ana Maria Rodrigues; Jacinta Azevedo; João Alves; João Roxo; Miguel Rocha; Rita Côrte-Real; Luís Vieira; Maria José Borrego; João Paulo Gomes
Journal:  Microb Genom       Date:  2019-11

6.  Genetic diversity in the plasticity zone and the presence of the chlamydial plasmid differentiates Chlamydia pecorum strains from pigs, sheep, cattle, and koalas.

Authors:  Martina Jelocnik; Nathan L Bachmann; Bernhard Kaltenboeck; Courtney Waugh; Lucy Woolford; K Natasha Speight; Amber Gillett; Damien P Higgins; Cheyne Flanagan; Garry S A Myers; Peter Timms; Adam Polkinghorne
Journal:  BMC Genomics       Date:  2015-11-04       Impact factor: 3.969

7.  From genomes to genotypes: molecular epidemiological analysis of Chlamydia gallinacea reveals a high level of genetic diversity for this newly emerging chlamydial pathogen.

Authors:  Weina Guo; Martina Jelocnik; Jing Li; Konrad Sachse; Adam Polkinghorne; Yvonne Pannekoek; Bernhard Kaltenboeck; Jiansen Gong; Jinfeng You; Chengming Wang
Journal:  BMC Genomics       Date:  2017-12-06       Impact factor: 3.969

8.  Population-based analysis of ocular Chlamydia trachomatis in trachoma-endemic West African communities identifies genomic markers of disease severity.

Authors:  A R Last; H Pickering; C H Roberts; F Coll; J Phelan; S E Burr; E Cassama; M Nabicassa; H M B Seth-Smith; J Hadfield; L T Cutcliffe; I N Clarke; D C W Mabey; R L Bailey; T G Clark; N R Thomson; M J Holland
Journal:  Genome Med       Date:  2018-02-26       Impact factor: 11.117

9.  The Nature and Extent of Plasmid Variation in Chlamydia trachomatis.

Authors:  Charlotte A Jones; James Hadfield; Nicholas R Thomson; David W Cleary; Peter Marsh; Ian N Clarke; Colette E O'Neill
Journal:  Microorganisms       Date:  2020-03-06

10.  Ongoing evolution of Chlamydia trachomatis lymphogranuloma venereum: exploring the genomic diversity of circulating strains.

Authors:  Helena M B Seth-Smith; Angèle Bénard; Sylvia M Bruisten; Bart Versteeg; Björn Herrmann; Jen Kok; Ian Carter; Olivia Peuchant; Cécile Bébéar; David A Lewis; Teresa Puerta; Darja Keše; Eszter Balla; Hana Zákoucká; Filip Rob; Servaas A Morré; Bertille de Barbeyrac; Juan Carlos Galán; Henry J C de Vries; Nicholas R Thomson; Daniel Goldenberger; Adrian Egli
Journal:  Microb Genom       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.